Characterization of DNA damage repair (DDR) alterations and the tumor immune microenvironment (TIME) in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Sankar, Kamya
Mercer, Jacob
Jaeger, Ellen B.
Godden, Jen
Berkman, Jonathan David
Williams, Edward
Thompson, Michael A.
Patel, Shetal Arvind
Reckamp, Karen L.
Weinberg, Frank
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA USA
[2] Tempus AI, Chicago, IL USA
[3] Tempus Labs Inc, Chicago, IL USA
[4] VCU Massey Canc Ctr, Richmond, VA USA
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Univ Illinois, Dept Hematol Oncol, Coll Med, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8603
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] The effect of chemotherapy on the tumor immune microenvironment in non-small cell lung cancer (NSCLC): A single-institution retrospective analysis.
    Devitt, Michael Edward
    Gade, Kristine E.
    Hall, Richard Delmar
    Horton, Bethany J.
    Stelow, Edward B.
    Bullock, Timothy
    Gentzler, Ryan D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [42] EFFECT OF GERMLINE POLYMORPHISMS OF DNA REPAIR GENES ON CHEMOTHERAPY OUTCOME IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Sullivan, I. G.
    Majem Tarruella, M.
    Paez, D.
    Pallares, C.
    Pare, L.
    Del Rio, E.
    Lopez Pousa, A.
    Barnadas, A.
    Ramon Y Cajal, T.
    Baiget, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 408 - 408
  • [43] Clinical significance of the tumor microenvironment in non-small cell lung cancer
    Shimizu, Katsuhiko
    Okita, Riki
    Nakata, Masao
    ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [44] New Insight of Tumor Microenvironment in Non-Small Cell Lung Cancer
    Sever, Tolga
    Leblebici, Asim
    Koc, Altug
    Binicier, Cilem
    Olgun, Aybuke
    Edizer, Deniz Tuna
    Ozdemir, Taha Resid
    Serin, Gurdeniz
    Erdem, Melek
    Basbinar, Yasemin
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (02): : 113 - 120
  • [45] Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
    Yao, Yu
    Liu, Jinghao
    Li, Lei
    Yuan, Yuan
    Nan, Kejun
    Wu, Xin
    Zhang, Zhenyu
    Wu, Yi
    Li, Xin
    Zhu, Jiaqi
    Meng, Xuehong
    Wei, Longgang
    Chen, Jun
    Jiang, Zhi
    ONCOTARGET, 2017, 8 (02) : 2130 - 2140
  • [46] Circulating tumor DNA detection in advanced non-small cell lung cancer patients
    Guo, Zhi-Wei
    Li, Min
    Li, Ji-Qiang
    Zhou, Chun-Lian
    Zhai, Xiang-Ming
    Li, Ming
    Wu, Ying-Song
    Yang, Xue-Xi
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 878 - +
  • [47] Biomarkers in immune microenvironment for predicting the efficacy of immunotherapy with or without chemotherapy in non-small cell lung cancer (NSCLC)
    Deng, R.
    Li, X.
    Xi, W.
    Deng, W.
    Ma, X.
    Ni, Y.
    Song, C.
    Tian, M.
    Wu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S405 - S405
  • [48] Combining immune checkpoint inhibition and DNA damage repair (DDR) targeted therapy in small cell lung cancer (SCLC)
    Sen, Triparna
    Chen, Limo
    Rodriguez, Bertha Leticia
    Yang, Yongbin
    Fan, You Hong
    Stewart, Catherine Allison
    Glisson, Bonnie
    Piwnica-Worms, Helen
    Sage, Julien
    Heymach, John V.
    Gibbons, Don L.
    Byers, Lauren A.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [49] Alteration in tumor immune microenvironment after chemo-radiotherapy for locally advanced non-small cell lung cancer.
    Yoneda, Kazue
    Kuwata, Taiji
    Mori, Masataka
    Kanayama, Masatoshi
    Kuroda, Koji
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer
    Ricciuti, Biagio
    Recondo, Gonzalo
    Spurr, Liam F.
    Li, Yvonne Y.
    Lamberti, Giuseppe
    Venkatraman, Deepti
    Umeton, Renato
    Cherniack, Andrew D.
    Nishino, Mizuki
    Sholl, Lynette M.
    Shapiro, Geoffrey, I
    Awad, Mark M.
    Cheng, Michael L.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 4135 - 4142
12345